"assignee ASTRAZENECA AB" — IP Library Search

← Prev Next →

BILIARY TRACT CANCER TREATMENT WITH ANTI-CLAUDIN 18.2 ADC

App. 19/413,978 Filed 2025-12-09 Docketed New Case - Ready for Examination

Patent Order

METHODS OF TREATING HEART FAILURE WITH PRESERVED EJECTION FRACTION EMPLOYING DAPAGLIFLOZIN AND COMPOSITIONS COMPRISING THE SAME

App. 19/361,422 Filed 2025-10-17 Docketed New Case - Ready for Examination

Patent Order

JAK1 SELECTIVE INHIBITORS

App. 19/345,428 Filed 2025-09-30 Docketed New Case - Ready for Examination

Patent Order

SUBSTITUTED INDAZOLES AS IRAK4 INHIBITORS

App. 19/343,252 Filed 2025-09-29 Docketed New Case - Ready for Examination

Patent Order

CHEMICAL COMPOUNDS

App. 19/297,723 Filed 2025-08-12 Docketed New Case - Ready for Examination

Patent Order

COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES

App. 19/296,221 Filed 2025-08-11 Docketed New Case - Ready for Examination

Patent Order

Dosage Regimen for the Treatment of Cancer

App. 19/240,036 Filed 2025-06-17 Docketed New Case - Ready for Examination

Patent Order

ANTI-IL5R ANTIBODY FORMULATIONS

App. 19/239,027 Filed 2025-06-16 Docketed New Case - Ready for Examination

Patent Order

NLRP3 INFLAMMASOME INHIBITORS

App. 19/135,584 Filed 2025-06-04 Application Undergoing Preexam Processing

Patent Order

CANCER THERAPY WITH CAPIVASERTIB AND FULVESTRANT

App. 19/133,762 Filed 2025-05-29 Docketed New Case - Ready for Examination

Patent Order

Assignee — page 1 of 335 ← Prev Next →